Clinical Trial Update: Study of the Role of Soluble Forms of RAGE (sRAGE/esRAGE) as Diagnostic and Prognostic Biomarkers of Systemic Lupus Erythematosus.

View source ↗

Summary

A clinical trial evaluating whether soluble forms of RAGE (sRAGE/esRAGE) can serve as diagnostic and prognostic biomarkers for systemic lupus erythematosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Snippet

Sponsor: CHU de Reims | Conditions: Lupus Erythematosus | Status: UNKNOWN